SCR-LIP-000608 · Claim · machine-readable JSON →

No objective diagnostic tool or biomarker for lipedema is yet standardised or validated for routine clinical use.

General proposition consolidated from 3 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
moderate (GRADE)
Evidence
4 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20202025Lipedema—Pathogenesis, Diagnosis, and Treatment Options — Kruppa et al. (2020) · consistentEditorial for “Subcutaneous Adipose Tissue Edema in Lipedema Revealed by Noninvasive 3T Magnetic Resonance Lymphangiography” — Wang (2023) · consistentDiagnostic imaging in lipedema: A systematic review — van la Parra et al. (2024) · consistentAssessment Tools to Quantify the Physical Aspects of Lipedema: A Systematic Review — Eason et al. (2025) · consistent

Evidence (4)

Context (PECO)

Populationwomen with lipedema across 20 studies
Conditionlipedema
Exposureimaging and measurement tools for lipedema quantification
Outcomeconsistency and clinimetric validity of assessment tools
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log